Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Preston

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Virology|November 2, 2001
Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vectorG Sun, P K O'Neil, H Yu, et al.
Journal of Virology|March 14, 1998
A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidineR A Smith, K M Remington, B D Preston, et al.
Journal of Virology|January 11, 2000
High rate of recombination throughout the human immunodeficiency virus type 1 genomeA E Jetzt, H Yu, G J Klarmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1991
The vinyl chloride DNA derivative N2,3-ethenoguanine produces G----A transitions in Escherichia coliK C Cheng, B D Preston, D S Cahill, et al.
Molecular and Cellular Biology|February 1, 1989
Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitroJ D Roberts, B D Preston, L A Johnston, et al.
IARC Scientific Publications|January 1, 1987
O-Alkyl deoxythymidines are recognized by DNA polymerase I as deoxythymidine or deoxycytidineB Singer, S J Spengler, F Chavez, et al.
Nature Medicine|June 1, 2001
Defective DNA polymerase-delta proofreading causes cancer susceptibility in miceR E Goldsby, N A Lawrence, L E Hays, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2',3'-dideoxy-3'-thiacytidineR A Smith, G J Klarmann, K M Stray, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
A genetic system to identify DNA polymerase beta mutator mutantsS L Washington, M S Yoon, A M Chagovetz, et al.
Regulatory Toxicology and Pharmacology : RTP|January 9, 2016
HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approachH Lebrec, F R Brennan, H Haggerty, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Virology|November 2, 2001
Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vectorG Sun, P K O'Neil, H Yu, et al.
Journal of Virology|March 14, 1998
A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidineR A Smith, K M Remington, B D Preston, et al.
Journal of Virology|January 11, 2000
High rate of recombination throughout the human immunodeficiency virus type 1 genomeA E Jetzt, H Yu, G J Klarmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1991
The vinyl chloride DNA derivative N2,3-ethenoguanine produces G----A transitions in Escherichia coliK C Cheng, B D Preston, D S Cahill, et al.
Molecular and Cellular Biology|February 1, 1989
Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitroJ D Roberts, B D Preston, L A Johnston, et al.
IARC Scientific Publications|January 1, 1987
O-Alkyl deoxythymidines are recognized by DNA polymerase I as deoxythymidine or deoxycytidineB Singer, S J Spengler, F Chavez, et al.
Nature Medicine|June 1, 2001
Defective DNA polymerase-delta proofreading causes cancer susceptibility in miceR E Goldsby, N A Lawrence, L E Hays, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2',3'-dideoxy-3'-thiacytidineR A Smith, G J Klarmann, K M Stray, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
A genetic system to identify DNA polymerase beta mutator mutantsS L Washington, M S Yoon, A M Chagovetz, et al.
Regulatory Toxicology and Pharmacology : RTP|January 9, 2016
HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approachH Lebrec, F R Brennan, H Haggerty, et al.
Pageof 5